PTX3-Based Genetic Testing for Risk of Aspergillosis after Lung Transplant

Clinical Infectious Diseases

Volumn 61, Issue 12, 2015, Pages 1893-1894

  Cunha, Cristina ^a,b   Monteiro, Alexandre A ^c,d   Oliveira Coelho, Ana ^a,b   Kühne, Juliana ^c,d   Rodrigues, Fernando ^a,b   Sasaki, Sergio D ^a,b,e   Schio, Sadi M ^d   Camargo, José J ^d   Mantovani, Alberto ^f,g   Carvalho, Agostinho ^a,b   Pasqualotto, Alessandro C ^c,d  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^d Department of Gastroenterology and Digestive Endoscopy Santa Casa Hospital   (Portugal)

^e UNIVERSIDADE FEDERAL DO ABC   (Brazil)

^f HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^g HUMANITAS UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; MYCOPHENOLATE MOFETIL; PENTRAXIN 3; C REACTIVE PROTEIN; SERUM AMYLOID P;

BRONCHIECTASIS; CYTOMEGALOVIRUS INFECTION; GENETIC SCREENING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INVASIVE ASPERGILLOSIS; KIDNEY GRAFT; LETTER; LUNG EMPHYSEMA; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; PRIORITY JOURNAL; ADVERSE EFFECTS; FEMALE; FUNGUS; GENETIC POLYMORPHISM; GENETICS; IMMUNOCOMPROMIZED PATIENT; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MYCOSIS; ORGAN TRANSPLANTATION;

C-REACTIVE PROTEIN; FEMALE; FUNGI; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MYCOSES; ORGAN TRANSPLANTATION; POLYMORPHISM, GENETIC; SERUM AMYLOID P-COMPONENT;

EID: 84961615106     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ679     Document Type: Letter

References (8)

1. Wojtowicz A, Lecompte TD, Bibert S, et al. PTX3 polymorphisms and invasive mold infections after solid organ transplant. Clin Infect Dis 2015; 61:619-22.
2. Cunha C, Aversa F, Lacerda JF, et al. Genetic PTX3 deficiency and aspergillosis in stemcell transplantation. N Engl J Med 2014; 370: 421-32.
3. Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010; 50:1101-11.
4. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46:1813-21.
5. Bozza S, Bistoni F, Gaziano R, et al. Pentraxin 3 protects from MCMVinfection and reactivation through TLR sensing pathways leading to IRF3 activation. Blood 2006; 108:3387-96.
6. Garlanda C, Hirsch E, Bozza S, et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 2002; 420:182-6.
7. Mauri T, Coppadoro A, Bombino M, et al. Alveolar pentraxin 3 as an early marker of microbiologically confirmed pneumonia: A threshold-finding prospective observational study. Crit Care 2014; 18:562.
8. Cunha C, Aversa F, Romani L, Carvalho A. Human genetic susceptibility to invasive aspergillosis. PLoS Pathog 2013; 9:e1003434.